| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Hepion Pharmaceuticals, Inc. | CEO and Director, Director | Common Stock | 50,470 | $153,934 | $3.05 | 18 Sep 2023 | Direct |
| Aurinia Pharmaceuticals Inc. | Director | Stock Option (right to buy) | 32,900 | 21 Sep 2023 | Direct | ||
| Aurinia Pharmaceuticals Inc. | Director | Restricted Stock Units | 20,383 | 21 Sep 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | 21 Sep 2023 | 2 | $0 | 4 | Director | 22 Sep 2023, 17:36 |
| AUPH | Aurinia Pharmaceuticals Inc. | 21 Sep 2023 | 0 | $0 | 3 | Director | 22 Sep 2023, 17:31 |
| HEPA | Hepion Pharmaceuticals, Inc. | 18 Sep 2023 | 1 | +$8,960 | 4 | CEO and Director, Director | 19 Sep 2023, 10:01 |
| HEPA | Hepion Pharmaceuticals, Inc. | 15 Sep 2023 | 1 | +$8,640 | 4 | CEO,CSO and Director, Director | 18 Sep 2023, 09:00 |
| HEPA | Hepion Pharmaceuticals, Inc. | 18 May 2021 | 1 | $0 | 4 | CEO, CSO and Director, Director | 20 May 2021, 16:36 |